Home/Smart Money/DIADEMA PARTNERS LP
§ 13F · FUND PROFILE

DIADEMA PARTNERS LP.

AUM · $144M (13F)Positions · 59Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$162M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1VKTXVIKING THERAPEUTICS INC1.22M$48M6.0%+70%
2ABVXABIVAX SA349K$47M5.9%+177%
3BMYBRISTOL-MYERS SQUIBB CO600K$35M4.4%NEW
4ABVXABIVAX SA252K$34M4.3%—
5UTHRUNITED THERAPEUTICS CORP DEL53K$29M3.6%−39%
6RVMDREVOLUTION MEDICINES INC139K$26M3.3%−33%
7ABVXABIVAX SA164K$22M2.7%—
8COGTCOGENT BIOSCIENCES INC494K$19M2.4%+53%
9BMYBRISTOL-MYERS SQUIBB CO331K$19M2.4%—
10BBIO 1.75 03/01/31BRIDGEBIO PHARMA INC250K$19M2.4%±0%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE DIADEMA SIGNAL

AC read

DIADEMA PARTNERS LP is a Other fund managing $144 million in assets. The fund runs a portfolio of 59 positions.

Read the full dossier →